Undergraduate: University of Washington
Medical School: Medical College of Wisconsin
Residency: University of North Carolina Hospitals
Research & Career Path
Breast cancer, cancer genomics
James A. Bryan, II Award for Clinical Excellence (2018)
Naqash A, File D, Ziemer C, Whang Y, Landman P, Googe P, Collichio F. Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series. J Immunother Cancer. 2019; 7:4.
File D, Grilley-Olson JE. Can we predict the response to therapy in soft tissue sarcoma? Future Oncol. 2018 Jan;14(2):101-104.
File D, Whittle J, Arce-Lara CE, Santana-Davila R. Impact of Pretreatment Variables on Overall Survival of Patients with Stage IV NSCLC. An Analysis of the Veterans Affairs Central Cancer Registry. Poster Presentation. American Society of Clinical Oncology Annual Meeting. 2014.
John William Pope Foundation (2019-Present)
Perou Laboratory Member (2019-Present)
- Immunotherapy Toxicity Committee Member (2019-Present)
- Molecular Tumor Board Member (2019-Present)